asacol 400 mg gastrorezistentne tablete
tillotts pharma gmbh - mesalazin - gastrorezistentna tableta - mesalazin 400 mg / 1 tableta - mesalazin
asacol 800 mg gastrorezistentne tablete
tillotts pharma gmbh - mesalazin - gastrorezistentna tableta - mesalazin 800 mg / 1 tableta - mesalazin
asacol 800 mg gastrorezistentne tablete
tillotts pharma gmbh - mesalazin - gastrorezistentna tableta - mesalazin 800 mg / 1 tableta - mesalazin
budezonid ferring 9 mg tablete s podaljšanim sproščanjem
ferring gmbh - budezonid - tableta s podaljšanim sproščanjem - budezonid 9 mg / 1 tableta - budezonid
dasatinib krka 100 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 100 mg / 1 tableta - dasatinib
dasatinib krka 50 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 50 mg / 1 tableta - dasatinib
dasatinib krka 70 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 70 mg / 1 tableta - dasatinib
dasatinib krka 20 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 20 mg / 1 tableta - dasatinib
dasatinib krka 100 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 100 mg / 1 tableta - dasatinib
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.